North America Clinical Trial Supplies Market Size & Outlook
North America clinical trial supplies market, 2018-2030 (US$M)
Related Markets
North America clinical trial supplies market highlights
- The North America clinical trial supplies market generated a revenue of USD 1,430.5 million in 2023.
- The market is expected to grow at a CAGR of 6.4% from 2024 to 2030.
- In terms of segment, phase iii was the largest revenue generating phase in 2023.
- Phase I is the most lucrative phase segment registering the fastest growth during the forecast period.
- Country-wise, U.S. is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 1,430.5 million |
| Market revenue in 2030 | USD 2,206.3 million |
| Growth rate | 6.4% (CAGR from 2023 to 2030) |
| Largest segment | Phase iii |
| Fastest growing segment | Phase I |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Phase I, Phase II, Phase III |
| Key market players worldwide | Almac Group, Catalent Inc, Waldencast PLC Class A, PCI Technology, Sharp Corp, Thermo Fisher Scientific Inc, PAREXEL, Marken, KLIFO, BioCair |
Other key industry trends
- In terms of revenue, North America region accounted for 55.5% of the global clinical trial supplies market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 704.4 million by 2030.
Phase iii was the largest segment with a revenue share of 52.05% in 2023. Horizon Databook has segmented the North America clinical trial supplies market based on phase i, phase ii, phase iii covering the revenue growth of each sub-segment from 2018 to 2030.
North America accounts for the highest number of clinical trials conducted among all regions, which is a major driver for the growth of clinical trial supplies market in this region. Increase in the number of clinical trials & players in clinical trial supplies market and availability of advanced technology are among factors responsible for the dominance of this region.
Majority of the clinical trials are conducted in countries such as the U.S. and Canada in the region. English is a widely used language in this region, which reduces the language barrier. Hence, North America is preferred for conducting clinical trials.
Majority of the CROs and biopharmaceutical companies are present in this region and with advancements in technology, the demand for effective supplies is increasing. Hence, this region is expected to witness considerable growth in clinical trial supplies market over the forecast period.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clinical Trial Supplies Market Scope
Clinical Trial Supplies Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America clinical trial supplies market size, by country, 2018-2030 (US$M)
North America Clinical Trial Supplies Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
